Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Kaiseron Jul 28, 2021 1:52pm
79 Views
Post# 33617408

RE:You'll never understand it Kaiser

RE:You'll never understand it Kaiser

What you'll never understand is you are assuming! 

Assumptions are wrong more often than not. Case in point stock is down over 13% now.

Keep pumping tho.  Get your buddy no knowledge moe to help.

whisky11 wrote: At the time of my writing today, stock price dropped something like between 2 and 3% assuming that they borrowed the shares at yesterday close and they are 33% of all activity today. They got 1% of the drop differential between yesterday sp and stock price at time of my writing.
They could make  much less, they have to pay fee for borrowed shares.

 

<< Previous
Bullboard Posts
Next >>